Kodiak Confirms Potential of MPD Northwest Claims and Adds Further Strategic Claims; New Focus Area for 2025
Kodiak collected a total of 38 rock samples from prospecting on the MPD Northwest claim block in 2024. The focus was to obtain representative samples from most mineralized targets to confirm grades ...
SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...